NIH-funded research NIH-funded research

Health and Aging Brain — focusing on Alzheimer's in diverse communities

Official title: The Health & Aging Brain Study - Health Disparities (HABS-HD)

Funded at University of North Texas Hlth Sci Ctr · NIH-11173807 · Data updated 2026-11-12

This project compares brain scans, blood tests, and other measures in older African American and Hispanic adults to better understand Alzheimer's disease.

More Aging research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of North Texas Hlth Sci Ctr
NIH-funded
Lab location1 site (Fort Worth, United States)
Project startSeptember 30, 2022
Project endAugust 31, 2027
Funding year2025
Award (this year)$31,789,574
NIH project number5U19AG078109-04
Project IDNIH-11173807 on NIH RePORTER

Who could benefit from this research

Could help

Adults aged 21 and older—particularly African American or Hispanic (including Mexican American) adults—with or without Alzheimer's disease or related memory concerns are ideal candidates.

Less likely to help

People seeking an immediate treatment or cure for dementia are unlikely to receive direct therapeutic benefit from this observational and biomarker-focused research.

What this research studies

If you join, researchers will collect brain imaging, blood and other fluid samples, genetic tests, and information about your health, social background, and environmental exposures. They will apply the AT(N) biomarker framework (amyloid, tau, neurodegeneration) to participants from African American and Hispanic communities. The work is community-based and follows people over time to link biomarkers with memory and thinking changes. Study visits are designed to be local and culturally sensitive to improve participation and trust.

Why it matters

Potential benefit: If successful, this work may lead to more accurate diagnosis and better-targeted treatments for Alzheimer's disease in African American and Hispanic older adults.

How similar studies have gone: The AT(N) biomarker framework has guided research and some drug trials in mostly white cohorts, but applying these biomarkers to African American and Hispanic populations is relatively new.

Where this research is happening

  • University of North Texas Hlth Sci Ctr
    Fort Worth, United States
    Active

Researchers

  • Principal investigator: O'bryant, Sid E — University of North Texas Hlth Sci Ctr
  • Study coordinator: O'bryant, Sid E

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.